Computerized systems are used throughout the life sciences industry to support various regulated activities, which in turn generate many types of electronic records.
These electronic records must be maintained according to regulatory requirements contained within FDA's 21 CFR Part 11 for US jurisdictions and Eudralex Volume 4 Annex 11 for EU jurisdictions.
One of the requirements for such compliance is the generation and review of audit trails. Thousands of audit trail records can be generated on a daily basis.
Why should you Attend: This webinar will demystify audit trails and describe the benefits of audit trail for your company. Attendees will the tools required to generate compliant audit trails on a domestic and international basis and will answer the questions on how to handle systems without automated audit trails, in a compliant manner.
Additionally, attendees will learn how to review audit trails, using a risk based approach to cull through the thousands of audit trail records that can be generated on a daily basis.
Areas Covered in the Session:
- What is an Audit Trail
- 21 CFR 11/ Annex 11 requirements for Audit Trails
- Why Audit Trails
- What are Audit Trail Features
- What are Audit Trail Contents
- What records need to have an Audit Trail
- When does Audit Trail begin
- What clock should be used for the timestamp
- How is Audit Trail versioned
- How is Audit Trail stored
- What if my system does not have automated Audit Trail
- What about 'hybrid' systems
- How to review audit trails
- Risk Based Approach
- Best Practices
- Audit Trail and Data Integrity
Speakers
Ms Angela Bazigos,
CEO ,
Touchstone Technologies Silicon ValleyAngela Bazigos.CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Positions include Chief Compliance Officer at Morf Media. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA. Patent on speeding up software compliance. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom. National Trainer for Society of Quality Assurance. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford’s Who’s Who for Life Sciences.
Who Should Attend
- Quality Managers
- Quality Engineers
- Small Business Owners
- GxP
- Consultants
- Quality VPs
- IT VPs
- FDA Investigators
- Other Regulatory Agency Investigators
